Component Profiles
What Is In KLOW?
BPC-15715 amino acids, 1,419 Da
TB-50043 amino acids, 4,963 Da
GHK-Cu3 amino acids + Cu²⁺, 403 Da
KPV3 amino acids (Lys-Pro-Val), 342 Da
Total peptides4 distinct compounds
MechanismsComplementary pathways
⚠️ FOR RESEARCH PURPOSES ONLY — This compound is not FDA approved. All data presented is from clinical trials for educational reference.
Cellular Peptide Blend
KLOW
KLOW BlendQuad Regenerative StackBPC + TB4 + Copper Peptide + KPVAnti-Inflammatory Regeneration QuadGLOW + KPV
A quad-peptide combination of BPC-157, TB-500, GHK-Cu, and KPV targeting complementary angiogenic, cellular migration, extracellular matrix remodeling, and anti-inflammatory pathways in preclinical research. Premium Research Peptide.
Dosage
Quantity
1
$129.99
Dosage
Quantity
1
$129.99
Tue, Apr 28 - Mon, May 4
Overnight shipping available
We accept
KLOW$129.99
Free shippingon orders over $150
Damageprotection
Secure checkout256-bit SSL
Compound Information
Technical specifications for each component
PubChem Databases
KPV Structure
Alpha-MSH C-Terminal Fragment
SequenceLys-Pro-Val (KPV)
Molecular formulaC₁₆H₃₀N₄O₄
Molecular weight342.43 g/mol
Originα-MSH residues 11-13
MechanismPepT1-mediated uptake
CAS Number67727-97-3
Storage Requirements
Stability Information
Freeze for storageRefrigerate after reconstitutionProtect from light
Lyophilized (powder)
-20°C long-term
Reconstituted
2-8°C•use within 7 days
Light protection
Store away from light
Research Status
Where Each Stands
BPC-157: PreclinicalTB-500: PreclinicalGHK-Cu: Cosmetic + ResearchKPV: Research Compound
BPC-157 studies200+ publications
TB-500 studies170+ publications
GHK-Cu studies130+ publications
KPV studies100+ publications
Combination studiesEmerging research
Sources & References
Peer-reviewed research
Gastroenterology
PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation
2008•DOI: 10.1053/j.gastro.2007.10.026•PMID: 18061177
Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, et al.
View Source
British Journal of Pharmacologyα-MSH Related Peptides: A New Class of Anti-Inflammatory and Immunomodulating Drugs
2007•DOI: 10.1111/j.1476-5381.2000.00178.x
Luger TA, Brzoska T, Scholzen TE, et al.
View Source
⚠️Important Research Notice
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
